The Tough Tech problem we are solving
The ability to precisely regulate gene expression remains the holy grail of modern medicine. While RNA-based approaches hold great promise, existing technologies face major limitations in precision, efficacy, and durability, leaving many diseases untreatable and the full potential of RNA medicine unrealized.
About our solution
Collage Bio is pioneering a novel class of RNA therapeutics that push beyond current limitations. With an AI-enhanced polynucleotide engineering framework, we create highly stable, specific, and programmable medicines to address unmet therapeutic needs. Our approach combines the durability of gene editing with the ability to modulate disease mechanisms safely and reversibly, enabling scalable and modular therapies for a wide range of diseases.